Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA weighs US approval of Glaxo's Cervarix, expanded use of Merck's Gardasil to boys
Yahoo/AP
Wednesday, September 9, 2009 - 8:59am
tags:
FDA, GSK, Merck, Gardasil, Cervarix, HPV, vaccines
More Health Care Stocks Primed for Short-Selling: Chanos
CNBC
Wednesday, September 9, 2009 - 8:50am
tags:
AstraZeneca
CytRx to repsond to FDA letter in 4Q
Bizjournals.com
Wednesday, September 9, 2009 - 8:36am
tags:
CytRx, FDA, arimoclomal, ALS
Vivus' obesity drug candidate hits weight reduction goals in 2 late-stage studies; shares soar
Yahoo/AP
Wednesday, September 9, 2009 - 8:27am
tags:
Vivus, obesity, Qnexa
Merck Jury Told to Keep Deliberating in Fosamax Case
Bloomberg
Wednesday, September 9, 2009 - 6:48am
tags:
Merck, lawsuits, osteoporosis, Fosamax
Botox May Get $1 Billion Face Lift as Allergan Migraine Drug
Bloomberg
Wednesday, September 9, 2009 - 6:46am
tags:
Allergan, Botox, migraines
Prices, Profits and the Economics of Big Pharma
Seeking Alpha
Wednesday, September 9, 2009 - 6:45am
tags:
Sanofi, Pfizer, JNJ, GSK, Bayer
Sanofi Grows Strong on Vaccines
Yahoo/Zacks.com
Tuesday, September 8, 2009 - 8:03pm
tags:
Sanofi, vaccines, Baxter International, GSK, AstraZeneca
Cell Therapeutics Fails to Impress
Yahoo/Zacks.com
Tuesday, September 8, 2009 - 8:01pm
tags:
Cell Therapeutics, Biogen Idec, Cephalon, pixantrone
Cornerstone Wins Factive Rights
Yahoo/Zacks.com
Tuesday, September 8, 2009 - 7:57pm
tags:
Cornerstone Therapeutics, Factive, AstraZeneca, GSK, Merck
Pfizer Rep Alleges Viagra Promoted With Unapproved Materials
BNET Pharma
Tuesday, September 8, 2009 - 2:03pm
tags:
Pfizer, Viagra
FDA backs HPV vaccines as panel vote looms
Fierce Biotech
Tuesday, September 8, 2009 - 2:01pm
tags:
FDA, vaccines, HPV, Gardasil, Cervarix, GSK, Merck
Osiris Drug's Failure Was Easy to Envision
TheStreet.com
Tuesday, September 8, 2009 - 1:57pm
tags:
Osiris Therapeutics, Prochymal
Sector Snap: Analyst keeps positive biotech view
Yahoo/AP
Tuesday, September 8, 2009 - 1:57pm
tags:
biotech, Biomarin, Amgen, Genzyme
Why Funds Missed Facet Biotech
Minyanville
Tuesday, September 8, 2009 - 1:53pm
tags:
Facet Biotech, M&A, Biogen Idec
Repros Therapeutics finds funding
Bizjournals.com
Tuesday, September 8, 2009 - 10:20am
tags:
Repros Therapeutics
GeoPharma settles with Consolidated Pharmaceutical
Bizjournals.com
Tuesday, September 8, 2009 - 9:43am
tags:
GeoPharma, settlements, Consolidated Pharmaceutical
Analyst upgrades Pharmasset, citing potential for developing hepatitis C drug
Yahoo/AP
Tuesday, September 8, 2009 - 9:05am
tags:
Pharmasset, upgrades, hepatitis C
Osiris Stem Cell Drug Fails
TheStreet.com
Tuesday, September 8, 2009 - 8:32am
tags:
Osiris Therapeutics, Prochymal
Facet Biotech rejects Biogen Idec's bid
Marketwatch
Tuesday, September 8, 2009 - 8:31am
tags:
Facet Biotech, Biogen Idec, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.